AVITA Medical Statistics

Total Valuation

AVITA Medical has a market cap or net worth of $144.41 million. The enterprise value is $162.66 million.

Market Cap	144.41M
Enterprise Value	162.66M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

AVITA Medical has 26.50 million shares outstanding. The number of shares has increased by 2.35% in one year.

Current Share Class	26.50M
Shares Outstanding	26.50M
Shares Change (YoY)	+2.35%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	1.84%
Owned by Institutions (%)	26.87%
Float	25.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.91
Forward PS	1.35
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.09

Current Ratio	2.09
Quick Ratio	1.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.24

Financial Efficiency

Return on equity (ROE) is -407.50% and return on invested capital (ROIC) is -54.81%.

Return on Equity (ROE)	-407.50%
Return on Assets (ROA)	-38.35%
Return on Invested Capital (ROIC)	-54.81%
Return on Capital Employed (ROCE)	-109.90%
Revenue Per Employee	$275,619
Profits Per Employee	-$219,408
Employee Count	260
Asset Turnover	0.86
Inventory Turnover	1.34

Taxes

In the past 12 months, AVITA Medical has paid $32,000 in taxes.

Income Tax	32,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.45% in the last 52 weeks. The beta is 1.55, so AVITA Medical's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	-31.45%
50-Day Moving Average	7.10
200-Day Moving Average	9.58
Relative Strength Index (RSI)	41.88
Average Volume (20 Days)	342,985

Short Selling Information

Short Interest	4.49M
Short Previous Month	3.96M
Short % of Shares Out	17.10%
Short % of Float	n/a
Short Ratio (days to cover)	14.54

Income Statement

In the last 12 months, AVITA Medical had revenue of $71.66 million and -$57.05 million in losses. Loss per share was -$2.19.

Revenue	71.66M
Gross Profit	61.25M
Operating Income	-51.21M
Pretax Income	-57.01M
Net Income	-57.05M
EBITDA	-49.77M
EBIT	-51.21M
Loss Per Share	-$2.19

Full Income Statement

Balance Sheet

The company has $25.82 million in cash and $44.07 million in debt, giving a net cash position of -$18.26 million or -$0.69 per share.

Cash & Cash Equivalents	25.82M
Total Debt	44.07M
Net Cash	-18.26M
Net Cash Per Share	-$0.69
Equity (Book Value)	-4.57M
Book Value Per Share	-0.17
Working Capital	25.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.38 million and capital expenditures -$8.25 million, giving a free cash flow of -$46.63 million.

Operating Cash Flow	-38.38M
Capital Expenditures	-8.25M
Free Cash Flow	-46.63M
FCF Per Share	-$1.76

Full Cash Flow Statement

Margins

Gross margin is 85.47%, with operating and profit margins of -71.47% and -79.61%.

Gross Margin	85.47%
Operating Margin	-71.47%
Pretax Margin	-79.56%
Profit Margin	-79.61%
EBITDA Margin	-69.45%
EBIT Margin	-71.47%
FCF Margin	n/a

Dividends & Yields

AVITA Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.35%
Shareholder Yield	-2.35%
Earnings Yield	-39.50%
FCF Yield	-32.29%

Analyst Forecast

The average price target for AVITA Medical is $16.50, which is 202.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.50
Price Target Difference	202.75%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	40.42%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 30, 2020. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Jun 30, 2020
Split Type	Reverse
Split Ratio	0.2:1

Scores

AVITA Medical has an Altman Z-Score of -6.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.37
Piotroski F-Score	3